microdosing on tirzepatide is not just about weight. It supports metabolic health, hormonal balance, and long-term wellness. This buzz-worthy term refers to doses of tirzepatide below the standard 2.5 mg minimum. For certain Tirzepatide Microdosing: The Growing Off-Label

These collective results support GIPR agonism as a key component for the enhanced efficacy of dual-agonists

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, which influence how your body responds to GLP-1 therapy

PlexusDx health questionnaires capture this history to flag potential concerns early

Weight loss can markedly reduce disease severity, and the recent TGA approval of tirzepatide for obstructive sleep apnoea in adults with obesity offers a novel adjunct to continuous positive airway pressure, broadening treatment strategies and improving long-term health outcomes

American health insurance has become a lot less generous

Complete guide with dosing protocols and research evidence